Ku, Benson S. http://orcid.org/0000-0001-6994-8770
Collins, Meghan
Anglin, Deidre M.
Diomino, Anthony M.
Addington, Jean http://orcid.org/0000-0002-8298-0756
Bearden, Carrie E. http://orcid.org/0000-0002-8516-923X
Cadenhead, Kristin S.
Cannon, Tyrone D. http://orcid.org/0000-0002-5632-3154
Cornblatt, Barbara A.
Druss, Benjamin G.
Keshavan, Matcheri http://orcid.org/0000-0002-5945-888X
Mathalon, Daniel H. http://orcid.org/0000-0001-6090-4974
Perkins, Diana O.
Stone, William S.
Tsuang, Ming T. http://orcid.org/0000-0002-0076-5340
Woods, Scott W.
Walker, Elaine F.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K23 MH129684, U01 MH066134, P50 MH066286, U01 MH081944, U01 MH081902, U01 MH081857, R01 MH076989, R01 U01 MH066069, U01 MH82022, U01 MH081988)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 28 April 2023
Revised: 16 June 2023
Accepted: 29 June 2023
First Online: 12 July 2023
Competing interests
: TDC has served as a consultant for Boehringer-Ingelheim Pharmaceuticals and Lundbeck A/S. DHM has served as a consultant for Aptinyx, Boehringer-Ingelheim Pharmaceuticals, Cadent Therapeutics, and Greenwich Biosciences. DOP has served as a consultant for Sunovion and Alkermes, has received research support from Boehringer-Ingelheim, and has received royalties from American Psychiatric Association Publishing. SWW has received investigator-initiated research support from Pfizer and sponsor-initiated research support from Auspex and Teva; he has served as a consultant for Biomedisyn (unpaid), Boehringer-Ingelheim, and Merck and as an unpaid consultant to DSM-5; he has been granted a patent for a method of treating prodromal schizophrenia with glycine; and he has received royalties from Oxford University Press. The other authors report no financial relationships with commercial interests.